OK Biotech Co., Ltd. (TPE:4155)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.35
+0.05 (0.38%)
At close: Mar 27, 2026
Market Cap1.88B -41.6%
Revenue (ttm)1.56B -6.8%
Net Income82.45M -12.3%
EPS0.57 -11.5%
Shares Out141.12M
PE Ratio23.44
Forward PEn/a
Dividend0.30 (2.25%)
Ex-Dividend DateJul 4, 2025
Volume128,305
Average Volume241,605
Open13.30
Previous Close13.30
Day's Range13.10 - 13.40
52-Week Range13.10 - 20.15
Beta0.15
RSI36.76
Earnings DateApr 2, 2026

About OK Biotech

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4155
Full Company Profile

Financial Performance

In 2025, OK Biotech's revenue was 1.56 billion, a decrease of -6.81% compared to the previous year's 1.67 billion. Earnings were 82.45 million, a decrease of -12.26%.

Financial Statements